CEC

The Clinical Trial Centre (CEC) performs clinical studies. CEC has dedicated facilities and updated ophthalmological equipment. Clinical patient-oriented research involves characterizing disease progression and testing new discoveries by carrying out carefully controlled research studies in patients, i. e., clinical trials. This includes testing not only new drugs, but also new methods, devices, imaging and surgical procedures as well as well-designed prospective, observational, longitudinal studies.

SERVICES
  • Randomized clinical trials
  • Clinical research studies
  • Testing new drugs, methods, devices, imaging and surgical procedures
  • Prospective, observational, longitudinal studies.

The Clinical Trial Centre (CEC) performs clinical studies. CEC has dedicated facilities and updated ophthalmological equipment. Clinical patient-oriented research involves characterizing disease progression and testing new discoveries by carrying out carefully controlled research studies in patients, i. e., clinical trials and other types of clinical studies. This includes testing not only new drugs, but also new methods, devices, imaging and surgical procedures as well as well-designed prospective, observational, longitudinal studies. Our research is focused in age-related eye diseases with special emphasis on diabetic retinopathy and age-related macular degeneration. CEC is certified as Clinical Site of Excellence by the EVICR.net – European Vision Institute Clinical Research Network (Clinical Site nº 1), that is a clinical trial centre in ophthalmology that complies with ICH GCP Guidelines with written SOPs. CEC has the necessary equipment and personnel to perform clinical trials and has proven expertise and scientific publications in this area.

Research Focus

Biomarkers of progression of Diabetic Retinopathy Vision Threatening Complications in Diabetic Retinopathy Progression Epidemiological characterization of AMD. Characterization of progression of AMD from intermediate to late forms of AMD Evaluation of novel treatment options for complications of Diabetic Retinopathy Validation Outcomes and testing treatments for sight threatening Age-Related Macular Degeneration

Areas of expertise

Retina: Identification of phenotypes and biomarkers of retinal disease progression Testing new methods of early diagnosis of macular edema and retinal vascular disease Characterisation of responders and non-responders to new available therapies of retinal disease Characterization of phenotypes of diabetic retinopathy Neurovascular degeneration in age-related disease   Glaucoma: Evaluation of new drugs for glaucoma treatment   Other: Optical Coherence Tomography in the diagnosis of neurological diseases Diagnostic correlations in imaging between brain and retina Eye fundus imaging as a predictor of systemic vascular disease Neurovascular degeneration in age-related disease

  • Director

    Inês Marques

  • Investigator

    André Coutinho

    Andreia Rosa

    Bruno Teixeira

    Celso Costa

    Conceição Lobo

    Filipe Mira Ferreira

    Inês Laíns

    Inês Pereira Marques

    Isabel Pires

    João Figueira

    João Pedro Marques

    Joana Costa

    Joaquim Neto Murta

    José Costa

    Lisa-Marie Anders

    Luís Silva Pires

    Maria Fonseca

    Marco Marques

    Maria João Quadrado

    Maria Luísa Ribeiro

    Maria Luz Cachulo

    Pedro Faria

    Philipp Anders

    Raquel Félix

    Rufino Silva

  • Laboratory Technician

    Filipe Martins

    Inês Rego

  • Study Coordinator

    Catarina Eloy

    Filipe Martins

    Marcela Pascoal

    Sandra Cristina Pardal

  • Technician for Diagnostic Procedures

    Ana Almeida

    Ana Nunes

    Ana Rocha

    Ana Rita Santos

    Diana Ramos

    Marta Lopes

  • Nurse

    Aida Cristina Vitorino

    Eugénia Cardoso

    Maria do Céu Simões

    Paulo Marques

    Tânia Mesquita

  • Pharmacist

    Joana Abrantes

    Patrícia Barreto

  • Secretary

    Sandra Cristina Pardal

  • Director Assistant

    Patrícia Barreto

  • Clients

    ‣ Alcon

    ‣ Alimera

    ‣ Allergan

    ‣ Bausch & Lomb

    ‣ Bayer

    ‣ Chiltern

    ‣ Eurotrials

    ‣ EyeTech

    ‣ Farmalabor

    ‣ IRIS Pharma

    ‣ Lilly

    ‣ Merck Sharp & Dohme

    ‣ Novartis

    ‣ OM Pharma

    ‣ Pfizer

    ‣ Pharmaceutical Product Development

    ‣ Pharmacia Corporation

    ‣ Sanofi-Aventis

    ‣ Servier

    ‣ Théa